Singapore Anti-aging Supplements Market Size & Outlook, 2026-2034
Singapore Anti-aging Supplements Market Insights
- Based on Deep Market Insights findings, the Singapore Anti-aging Supplements Market reached USD 18.39 Million in 2025 and is estimated to attain USD 35.3 Million by 2034.
- From 2026 to 2034, the Singapore market is expected to grow at a steady CAGR of 7.58%.
- Within the Ingredient category, Collagen dominated in 2025 in terms of market size contribution.
- Over the forecast period, NMN/NAD+ is forecasted to deliver the fastest growth, positioning it as the most lucrative Ingredient segment.
![Singapore Anti-aging Supplements Market Size, Share & Growth Report By [2034]](https://deepmarketinsights.com/uploads/charts/singapore-anti-aging-supplements-market-singapore-ingredient-24410.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, Singapore held 0.41% of the global Anti-aging Supplements Market size.
- By 2034, United States is anticipated to capture the largest share of the global Anti-aging Supplements Market.
- In Asia Pacific, China is expected to lead the regional Anti-aging Supplements Market size by 2034.
- Australia will remain the fastest-growing market in Asia Pacific, reaching USD 91.71 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 18.39 Million |
| Market Size In 2034 | USD 35.3 Million |
| Largest segment | Collagen |
| Units | Revenue in USD Million |
| CAGR | 7.58% (2026-2034) |
| Segmnetation Covered | |
| Ingredient |
|
| Benefit |
|
| Format |
|
| Channel |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Singapore Anti-aging Supplements Market Ingredient 2026-2034 (USD Million)
| Ingredient | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collagen | XX.x | XX.x | XX.x | 9.74 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| NMN/NAD+ | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Resveratrol | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Singapore Anti-aging Supplements Market Benefit 2026-2034 (USD Million)
| Benefit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skin | XX.x | XX.x | XX.x | 9.69 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Longevity | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cognitive | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Singapore Anti-aging Supplements Market Format 2026-2034 (USD Million)
| Format | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsule | XX.x | XX.x | XX.x | 8.83 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gummy | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powder | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Singapore Anti-aging Supplements Market Channel 2026-2034 (USD Million)
| Channel | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail | XX.x | XX.x | XX.x | 11.27 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Online | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.